Invasive Melanoma and Melanoma in Situ Treated With Modified Mohs Micrographic Surgery With En Face Permanent Sectioning: A 10-Year Retrospective Review

Dermatol Surg. 2020 Aug;46(8):1004-1013. doi: 10.1097/DSS.0000000000002246.

Abstract

Background: Successful surgical treatment of cutaneous melanoma is dependent on margin control.

Objective: To determine efficacy of modified Mohs micrographic surgery (mMMS) with en face permanent margins in management of invasive melanoma (IM) and melanoma in situ (MIS).

Methods: A retrospective cohort study evaluating local recurrence, 5-year recurrence-free survival, and 5-year melanoma-specific survival. Overall, 657 melanomas (128 IM and 529 MIS) from 631 patients were treated using mMMS during a 10-year period. Follow-up information was obtained from medical records and telephone encounters.

Results: The median follow-up time was 5.18 years. Most melanomas were located on the head and neck 93.6% (615/657). Margins required for clearance were 0.77 ± 0.44 cm (mean ± SD). Local recurrence was identified in 1.98% (13/657) of melanomas with no local recurrences in IM. Five-year local recurrence-free and melanoma-specific survival rates were estimated to be 96.9% (95% confidence interval [CI]: 94.6%-98.2%) and 99.0% (95% CI: 97.7%-99.6%). There were 5 melanoma-related deaths.

Conclusion: Modified Mohs micrographic surgery is an effective treatment of melanoma as evidenced by low local recurrence rates and high melanoma-specific survival.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Margins of Excision
  • Melanoma / secondary
  • Melanoma / surgery*
  • Middle Aged
  • Mohs Surgery / methods*
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local / pathology*
  • Retrospective Studies
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / surgery*
  • Survival Rate